Patients with an IL6 of >11.63 pg/mL had a 23-fold increased risk of iCCA [OR: 23.33 (6.42–84.83), p < 0.001] compared with those with a level of ≤11.635 pg/mL. This evidence concerns the gene IL6 and infantile convulsions and choreoathetosis.